Shulman, M., Hu, M., Sullivan, M. A., Greiner, M., Ohrtman, K., Opara, O., Nunes, E. V., & Bisaga, A. (2025). Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trials. The American Journal on Addictions. Portico. https://doi.org/10.1111/ajad.70055

Fahey, M. C., Gutkind, S., Kleykamp, B. A., McClure, E. A., Han, B., & Mauro, P. M. (2025). Prevalence and correlates of tobacco and cannabis co‐use among late middle‐aged (50–64 years) and older adults (65+ years) in the United States using pooled national survey data. The American Journal on Addictions. Portico. https://doi.org/10.1111/ajad.70053

Ware, O. D., Cano, M. T., Dalal Safa, M., Garza, N., Martinez, S., & Salloum, I. (2024). Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States. The American Journal on Addictions, 33(4), 400–408. Portico. https://doi.org/10.1111/ajad.13520

Mariani, J. J., Dobbins, R. L., Heath, A., Gray, F., & Hassman, H. (2023). Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs. The American Journal on Addictions, 33(1), 8–14. Portico. https://doi.org/10.1111/ajad.13484

Paschen‐Wolff, M., Greenfield, S. F., Kathryn McHugh, R., Burlew, K., Pavlicova, M., Choo, T., Barbosa‐Leiker, C., Ruglass, L. M., Mennenga, S., Rotrosen, J., Nunes, E. V., & Campbell, A. N. C. (2023). Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder. The American Journal on Addictions, 32(6), 584–592. Portico. https://doi.org/10.1111/ajad.13463

Tatar, M., Faraji, M. R., Keyes, K., Wilson, F. A., & Jalali, M. S. (2023). Social vulnerability predictors of drug poisoning mortality: A machine learning analysis in the United States. The American Journal on Addictions, 32(6), 539–546. Portico. https://doi.org/10.1111/ajad.13445

Carr, M. M., Mannes, Z. L., Oberleitner, L. M. S., Oberleitner, D. E., Beitel, M., Gazzola, M. G., Madden, L. M., Zheng, X., & Barry, D. T. (2023). The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment. The American Journal on Addictions, 32(5), 460–468. Portico. https://doi.org/10.1111/ajad.13432

Vest, N., Wenzel, K., Choo, T., Pavlicova, M., Rotrosen, J., Nunes, E., Lee, J. D., & Fishman, M. (2023). Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial. The American Journal on Addictions, 32(3), 291–300. Portico. https://doi.org/10.1111/ajad.13371

Mannelli, P., Douaihy, A. B., Akerman, S. C., Legedza, A., Fratantonio, J., Zavod, A., & Sullivan, M. A. (2022). Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting. The American Journal on Addictions, 31(2), 142–147. Portico. https://doi.org/10.1111/ajad.13264

Fishman, M., Wenzel, K., Scodes, J., Pavlicova, M., Campbell, A. N. C., Rotrosen, J., & Nunes, E. (2021). Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial. The American Journal on Addictions, 30(5), 433–444. Portico. https://doi.org/10.1111/ajad.13176

Mariani, J. J., Mahony, A. L., Podell, S. C., Brooks, D. J., Brezing, C., Luo, S. X., Naqvi, N. H., & Levin, F. R. (2021). Open‐label trial of a single‐day induction onto buprenorphine extended‐release injection for users of heroin and fentanyl. The American Journal on Addictions, 30(5), 470–476. Portico. https://doi.org/10.1111/ajad.13193